Palatin Technologies (PTN) Change in Inventory (2020 - 2023)
Palatin Technologies' (PTN) quarterly Change in Inventory came in at $2.2 million in Q4 2023, up 2155.77% on a YoY basis from $98707.0 in Q4 2022, and up 307.66% quarter-over-quarter from -$1.1 million in Q3 2023.
Analysis
Palatin Technologies (PTN) Change in Inventory (2020 - 2023) Analysis & Trends
Palatin Technologies (PTN) has reported Change in Inventory for 4 consecutive years, with $2.2 million the latest figure, recorded in Q4 2023.
- For the quarter ending Q4 2023, Change in Inventory rose 2155.77% year-over-year to $2.2 million; the trailing twelve-month figure through Sep 2024 stood at $2.2 million (up 400.78% YoY), and the FY2024 full-year result was $1.2 million, up 175.85% from the prior year.
- Change in Inventory advanced to $2.2 million in Q4 2023 per PTN's latest filing, from -$1.1 million in the prior quarter.
- Across five years, Change in Inventory topped out at $2.2 million in Q4 2023 and bottomed at -$1.1 million in Q3 2023.
- Historically, Change in Inventory has averaged $198399.4 across 4 years, with a median of $92601.5 in 2022.
- The widest YoY moves for Change in Inventory: up 2155.77% in 2023, down 1339.65% in 2023.
- Over 4 years, Change in Inventory stood at $188093.0 in 2020, then sank by 172.86% to -$137037.0 in 2021, then soared by 172.03% to $98707.0 in 2022, then surged by 2155.77% to $2.2 million in 2023.
- According to Business Quant data, Change in Inventory over the past three periods registered $2.2 million, -$1.1 million, and $104033.0 for Q4 2023, Q3 2023, and Q2 2023 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 31.00 Mn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 145.00 Mn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 27.70 Mn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 28.20 Mn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 132.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | -280,000.00 |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | -75.70 Mn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | - |
| 10 | Palatin Technologies | 46.98 Mn | 46.98 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | 2.23 Mn |
| Sep 30, 2023 | -1.07 Mn |
| Jun 30, 2023 | 104,033.00 |
| Mar 31, 2023 | 129,235.00 |
| Dec 31, 2022 | 98,707.00 |
| Sep 30, 2022 | 86,496.00 |
| Jun 30, 2022 | 347,541.00 |
| Mar 31, 2022 | -46,908.00 |
| Dec 31, 2021 | -137,037.00 |
| Sep 30, 2021 | 53,933.00 |
| Jun 30, 2021 | 1.28 Mn |
| Mar 31, 2021 | -510,216.00 |
| Dec 31, 2020 | 188,093.00 |
| Sep 30, 2020 | 25,200.00 |